Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
257M
-
Number of holders
-
487
-
Total 13F shares, excl. options
-
235M
-
Shares change
-
+6.61M
-
Total reported value, excl. options
-
$24.5B
-
Value change
-
+$667M
-
Put/Call ratio
-
1.56
-
Number of buys
-
251
-
Number of sells
-
-216
-
Price
-
$104.14
Significant Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q3 2015
573 filings reported holding VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock as of Q3 2015.
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) has 487 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 235M shares
of 257M outstanding shares and own 91.66% of the company stock.
Largest 10 shareholders include Capital World Investors (20.9M shares), FMR LLC (17.7M shares), PRICE T ROWE ASSOCIATES INC /MD/ (15M shares), VANGUARD GROUP INC (14.1M shares), WELLINGTON MANAGEMENT GROUP LLP (13.5M shares), JPMORGAN CHASE & CO (11.5M shares), AMERIPRISE FINANCIAL INC (10.2M shares), STATE STREET CORP (9.67M shares), Clearbridge Investments, LLC (7.79M shares), and BlackRock Institutional Trust Company, N.A. (6.17M shares).
This table shows the top 487 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.